Cargando…
Induction of apoptosis in prostate cancer by ginsenoside Rh2
The therapeutic action of ginsenoside Rh2 on several cancer models has been reported. This study aimed to evaluate its apoptotic effect on prostate cancer and the underlying mechanism. Cultured DU145 cells were treated with Rh2 (5 × 10(–5) to 1 × 10(–4) M), peroxisome proliferator-activated receptor...
Autores principales: | Tong-Lin Wu, Tony, Tong, Yat-Ching, Chen, I-Hung, Niu, Ho-Shan, Li, Yingxiao, Cheng, Juei-Tang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834249/ https://www.ncbi.nlm.nih.gov/pubmed/29541400 http://dx.doi.org/10.18632/oncotarget.24326 |
Ejemplares similares
-
Ginsenoside Rh2 Improves Cardiac Fibrosis via PPARδ–STAT3 Signaling in Type 1-Like Diabetic Rats
por: Lo, Shih-Hsiang, et al.
Publicado: (2017) -
The interaction of serum albumin with ginsenoside Rh2 resulted in the downregulation of ginsenoside Rh2 cytotoxicity
por: Lin, Yingjia, et al.
Publicado: (2017) -
The Dietary Furocoumarin Imperatorin Increases Plasma GLP-1 Levels in Type 1-Like Diabetic Rats
por: Wang, Lin-Yu, et al.
Publicado: (2017) -
Investigation of triamterene as an inhibitor of the TGR5 receptor: identification in cells and animals
por: Li, Yingxiao, et al.
Publicado: (2017) -
Ginsenoside Rh1 Alleviates HK-2 Apoptosis by Inhibiting ROS and the JNK/p53 Pathways
por: Yang, Qi, et al.
Publicado: (2020)